Projecting Cell & Gene Therapy Trajectories to Refine Adoption, Coverage & Pricing Decisions
- Integrating cell and gene therapy development success rate and market projections to clarify future coverage, adoption and cost implications
- Mapping indication level differences to show why cell and gene therapies cannot be treated as a single market and where payer and patient dynamics diverge
- Highlighting how insurance and delivery system innovations could impact real-world cell and gene therapy uptake